Denosumab biosimilar injection

denosumab biosimilar · Lambda Therapeutic Research Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Denosumab biosimilar injection, covering 2023-10-13 to 2023-10-13. Get the full timeline:

Most recent: Clinical Trial Update: Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis [Phase 3]